ISSN: 0939-5555

Journal Guideline

Annals of Hematology Q1 Unclaimed

Springer Verlag Germany

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.The Editor-in-Chief is Arnold Ganser, Department of Hematology, Hemostasis and Oncology, Medizinische Hochschule Hannover. Why publish with us We are a forum for clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology. We welcome articles in relevant aspects of oncology, molecular biology and immunology, and also covers diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. We provide high levels of author satisfaction, with 96% of our published authors reporting that they would definitely or probably publish with us again. It has an SJR impact factor of 0,912.

Annals of Hematology focuses its scope in these topics and keywords: thrombosis, working, society, hematology, patients, lymphoma, oncology, pediatric, treatment, clinical, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Hematology (Q2)

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,912

SJR Impact factor

93

H Index

467

Total Docs (Last Year)

1138

Total Docs (3 years)

15491

Total Refs

2575

Total Cites (3 years)

757

Citable Docs (3 years)

2.14

Cites/Doc (2 years)

33.17

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Proinflammatory syndrome mimicking acute rheumatoid arthritis in a patient with Waldenstrom's macroglobulinemia treated with rituximab

Subtotal splenectomy for the treatment of chronic lymphocytic leukemia

NADPH oxidase is not required for spontaneous and Staphylococcus aureus-induced apoptosis of monocytes

Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders

Thrombotic thrombocytopenic purpura: a rare cause of thrombocytopenia in HIV-infected hemophiliacs

Polymorphisms of interleukin-1 gene complex, IL6 and tumour necrosis factor genes in chronic idiopathic neutropenia of adults

Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996

Balancing analytical performance and medical reasoning: is carryover a critical issue in estimating low white blood cell numbers in bone marrow/stem cell transplant recipients?

Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma

IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-p)

Disseminated infection by Scedosporium Prolificans : an emerging fatality among haematology patients. Case report and review

Decreased frequency of HLA-B35 in patients with gastric MALT lymphoma

SHOW MORE ARTICLES

Mutations of the 5? noncoding region of the BCL-6 gene in primary bone lymphomas

Biotin labeling as an alternative nonradioactive approach to determination of red cell survival

Case of complete recovery of pancytopenia after treatment of hypopituitarism

Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients

Lytic infection of Epstein-Barr virus (EBV) in hemophagocytic syndrome associated with EBV-induced lymphoproliferative disorder

Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients

Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling?evaluation of risks and benefits

Combined ankyrin and spectrin deficiency in hereditary spherocytosis

Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias

Imatinib and beyond?the new CML study IV

Comparison of 5 vs 10 ¬µg/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer

Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome